HJLIW
Hancock Jaffe Laboratories Inc
Halal Rating :
Last Price
$0.02
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Exchange
Next Earnings Date
Hancock Jaffe Laboratories Inc. is a development-stage medical device company focused on developing tissue-based solutions for treating cardiovascular diseases. The company's lead product candidates include the VenoValve®, designed to treat chronic venous insufficiency in the deep veins of the leg, and the CoreoGraft®, a potential alternative to using saphenous vein grafts in coronary artery bypass surgeries.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Hancock Jaffe Laboratories Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.